Mode
Text Size
Log in / Sign up
N/A N=379

Double-J PLUS Postmarket Registry Study

Ureter Obstruction

Enrolled (actual)
379
Serious AEs
3.9%
Results posted
Oct 2024
Primary outcome: Primary: Percentage of Implanted Stents Meeting the Technical Success Criteria — 242; 158; 4; 2 Stent Implanted

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Boston Scientific Ureteral Stents, Urinary Diversion Stent (Device)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Boston Scientific Corporation
Primary completion
Jan 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Implanted Stents Meeting the Technical Success Criteria
242; 158; 4; 2
PRIMARY
Primary Safety Endpoint
2; 3; 213; 141
SECONDARY
Quality of Life - Patient-Reported Outcomes
-1.83; 2.04; -9.51; -10.79; -2.76; 2.25
SECONDARY
Stent Migration
3; 2; 260; 163

Summary

A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents

Eligibility Criteria

Inclusion Criteria (for all Ureteral stent types except Urinary Diversion Stents):

  • Subject is undergoing placement of a Boston Scientific Ureteral Stent
  • Subject anatomy is appropriate to accommodate a stent size available in the study
  • Subject is able to accurately detect and report bladder function and pain
  • Subject is willing and able to:
  • Complete patient QoL questionnaire at specified time points (for subjects aged ≥ 18 years)
  • Return for all follow-up visits

Inclusion Criteria (for Urinary Diversion Stents):

  • Subject is undergoing placement of a Boston Scientific Urinary Diversion Stent(s)
  • The anatomical features of the involved renal collecting system are known by either prior or concurrent urography or axial CT imaging
  • Subject is willing and able to return for all follow-up visits

Exclusion Criteria (for Ureteral stents and Urinary Diversion Stents):

  • Subjects who meet any of the contraindications per individual stent DFU
  • Subjects receiving different stent type in case of bilateral/multiple stenting
  • Subjects with an indwelling ureteral stent(s) not planned to be removed prior to/or concurrently with the study stent implant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04197583). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search